CDKN2A and neoplasm: The tumor samples from HPV-positive patients showed a higher level of CDKN2A as compared with those with negative HPV status (7.7355 (6.1427–10.592) vs. 3.0240 (1.7708–4.0156); p = 0.0034) (Figure 6).